Bristol Myers Squibb BMY Valuation Deep Dive Assessing If The LargeCap Pharma Name Is The Best Bargain In Big Pharma BILI Bilibili posts Q4 2025 EPS above consensus estimates stock rises 036 percent in regular trading Old ODFL Stock Is It Changing Trend Q4 2025 Better Than Expected MSBIP Midland tops Q1 2026 EPS estimates by 245 percent shares notch mild gains on investor optimism iShares Latin America 40 ETF ILF Outperforms Broader US Equities Amid Shifting Macro And Trade Policy Tailwinds